Sincerity Applied Materials Hldgs Corp (SINC)

[bjl]

Sincerity Applied Materials Holdings Corp (OTC: SINC) Reports Strong Q3 2024 Performance with Significant Revenue Growth in Australia, New Zealand, and U.S. Markets

SINC is expected to report over USD 230,000 in revenue from its operations in Australia and New Zealand, representing an impressive 1690% increase compared to Q3 2023. This dramatic growth underscores the company's expanding footprint and demand for its products in the region.

In the U.S., SINCs fully owned subsidiary, AgroShield, expects to report over USD 390,000 in revenue for Q3 2024, representing a 68% increase compared to Q3 2023. The company anticipates even stronger performance in Q4 2024, with projected revenues between USD 1-2 million, more than double the results of Q4 2023

As SINC approaches the end of 2024, the company expects consolidated revenues to reach approximately USD 4 million. While the Australian and New Zealand markets are anticipated to experience a quieter period leading into the Christmas season, the fourth quarter is traditionally the largest for AgroShield in the U.S., with substantial growth anticipated.

SINC is also excited to announce that its revolutionary quantum glass, currently undergoing NSF certification, is projected to hit the market by Q3 2025. This groundbreaking water filtration media is expected to generate an estimated USD 5 million+ in additional revenue, driven by strong commitments from existing clients in the water processing market. Furthermore, the company foresees massive opportunities in the wastewater, and drinking water treatment sectors in short terms, and in long term, bio-medical sectors.

Beyond water treatment, SINCs quantum glass, with its advanced nanopore structure, has immense potential in the medical field. Key areas of growth include:

Drug Delivery Systems: The precise control over pore size in nanoporous glass allows for the creation of controlled-release drug delivery systems. This technology can enable the slow and sustained release of medications, increasing the effectiveness of treatment for chronic diseases like cancer or diabetes while reducing side effects and the need for frequent dosing.
Biosensors: Nanoporous glass can be utilized in biosensor development due to its ability to detect and interact with biomolecules at a very fine scale. This can be crucial for developing diagnostic tools that monitor patient health in real-time or detect specific pathogens, enhancing early diagnosis and treatment effectiveness.
Tissue Engineering: The structural integrity and porosity of nanoporous glass make it an excellent material for scaffolding in tissue engineering. It can support the growth of new cells and tissues, making it ideal for applications such as regenerating damaged tissues, developing artificial skin, or supporting bone growth in orthopedic procedures.
Filtration and Sterilization: Due to its nanoporous nature, the material can efficiently filter out viruses, bacteria, and even DNA molecules. This ability to act as a sterilizing filter holds great promise for medical environments where infection control and maintaining sterile conditions are critical.
Implant Coatings: The biocompatibility of nanoporous glass, combined with its ability to promote cellular attachment, makes it a promising material for coating medical implants. This could improve the integration of implants with surrounding tissues, reduce rejection rates, and enhance the durability and success of procedures like joint replacements or dental implants.
These medical applications represent a significant growth opportunity for nanoporous glass, expanding its relevance far beyond water filtration and positioning SINC for sustained innovation and revenue expansion in the healthcare sector.

SINC would also like to reassure shareholders that the company has no current plans for dilutions or reverse stock splits. Any potential future offerings will be issued at market price.

We are thrilled with our Q3 performance and the strides weve made across both the Australian, New Zealand, and U.S. markets, said Yiwen (James) Zhang, CEO of Sincerity Applied Materials Holdings Corp. With our quantum glass set to hit the market in 2025, were confident in our ability to deliver even greater value to our shareholders in the years to come.

https://www.otcmarkets.com/stock/SINC/news/Sincerity-Applied-Materials-Holdings-Corp-OTC-SINC-Reports-Strong-Q3-2024-Performance-with-Significant-Revenue-Growth-in?id=454852